In addition, the inhibitory effect of TAM on tumor cell migration was associated with the blockade of the macrophage-specific immune checkpoint SHP1/SHP2, and reprogramming of the tumor-associated macrophages to the pro-inflammatory M1 phenotype via STAT6-inactivation. This evidence concerns the gene NR0B2 and neoplasm.